Study Links Omega-3 Supplements to Faster Cognitive Decline in Seniors

A study published on April 17, 2026, suggests that omega-3 supplementation may be associated with a faster rate of cognitive decline in some older adults, challenging the common belief that these supplements protect brain health.

The research, published in the Journal of Preventive Alzheimer’s Disease, analyzed data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a long-term project that monitors genetics, brain scans, memory, and aging.

The study was conducted by a team of researchers in China, including Zheng-Bin Liao and colleagues from the Third Military Medical University and Chongqing Medical University.

Study Design and Participant Matching

The researchers began their analysis with a group of 1,814 older adults. To ensure a fair comparison, the team matched omega-3 users with nonusers who shared similar characteristics.

Matching criteria included age, sex, diagnosis, and APOE ε4 status. Following this process, the final analysis focused on 273 supplement users and 546 nonusers.

The participants were tracked over a period of time with a median follow-up of 5 years.

Findings on Cognitive Decline

The study measured cognitive changes using three standard assessments: the Mini-Mental State Examination (MMSE), the Alzheimer’s Disease Assessment Scale Cognitive Subscale 13 (ADAS-Cog13), and the Clinical Dementia Rating Sum of Boxes (CDR-SB).

The results indicated that participants who used omega-3 supplements experienced a faster decline in cognitive function across all three of these measures compared to those who did not use the supplements.

Contrary to the prevailing hypothesis of a neuroprotective role, omega-3 supplementation was associated with accelerated cognitive decline

Researchers in the Journal of Preventive Alzheimer’s Disease

Research Limitations and Causality

The researchers noted that because the study was observational, the findings do not prove that omega-3 supplements cause cognitive decline.

Several variables could have influenced the results, as the study was unable to fully track certain details regarding the supplements used.

Factors that remained unmonitored include:

• The exact doses of the supplements taken by participants.
• The long-term adherence of users to their supplement routines.
• The overall quality of the supplements.
• Whether specific fish oil products had undergone oxidation.

These limitations mean that other factors may have contributed to the observed cognitive trajectories of the participants.